CrossrefInfokarte
Discovery and Advancement of Farnesyl Transferase Inhibitors as Potential Anticancer Therapeutic Agents: SCH 66336 a Case Study
Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents · 2001
DOI: 10.2174/1568013013359104 ↗Abstract
Kein Abstract verfügbar.
EUVIMED